American Journal of Alzheimer's Disease & Other Dementias

American Journal of Alzheimer's Disease & Other Dementias is a peer-reviewed clinical journal issued by SAGE Publications that deals with the day-to-day care of people living with dementia.《美国阿尔茨海默病与其他痴呆症杂志》是由 SAGE Publications 出版的同行评议临床期刊，关注痴呆症患者的日常诊疗与照护。

It has carried the present title since 2000, when the long-running Alzheimer's care magazine was relaunched for a research readership, and it entered MEDLINE with volume 16 in January 2001.该刊自 2000 年起使用现名，此前是一份面向照护实务的杂志，改刊后转向研究读者，并于 2001 年 1 月第 16 卷起进入 MEDLINE。

The 2025 Journal Impact Factor is 3.3, placing the title in the second quartile of both clinical neurology and geriatrics, and every article is published under gold open access.2025 年期刊影响因子为 3.3，在临床神经病学与老年医学两个类目均居 Q2，全部论文以金色开放获取方式出版。

Scope

• Coverage centres on Alzheimer's disease and the other progressive dementias, with an emphasis on what clinicians and care staff can apply at the bedside.报道范围以阿尔茨海默病及其他进行性痴呆症为核心，侧重临床医生与护理人员可以直接用于床旁的内容。
• Original research reports form the bulk of each volume, drawing on cohort studies, clinical trials and service evaluations from memory clinics and long-term care settings.原创研究构成每卷的主体，来源包括记忆门诊与长期照护机构的队列研究、临床试验和服务评估。
• Case studies describe diagnostic dilemmas, uncommon presentations and the practical handling of behavioural symptoms.病例研究记录诊断难题、少见表现以及行为症状的实际处理方式。
• Assessment and diagnosis receive sustained attention, from cognitive screening instruments to the workup that separates Alzheimer's disease from vascular dementia and from Lewy body disease.评估与诊断受到持续关注，从认知筛查工具到鉴别阿尔茨海默病、血管性痴呆与路易体痴呆的检查流程。
• Pharmacological topics cover cholinesterase inhibitors, memantine and the newer anti-amyloid antibodies, together with prescribing safety in frail older patients.药物治疗话题涵盖胆碱酯酶抑制剂、美金刚与新型抗淀粉样蛋白抗体，也讨论衰弱高龄患者的用药安全。
• Non-drug approaches carry equal weight, among them cognitive stimulation, exercise programmes, music and reminiscence work, and the design of care-home environments.非药物干预同样受重视，涉及认知刺激、运动方案、音乐与怀旧疗法以及照护机构的环境设计。
• Psychiatric comorbidity is a recurring theme, especially depression and delirium superimposed on dementia, which follows from the journal's early focus on clinical depression in later life.精神科共病是反复出现的主题，尤以叠加于痴呆症的抑郁和谵妄为多，这与该刊早期对老年期临床抑郁的关注一脉相承。
• Family caregivers appear throughout the literature here, in studies of burden, coping, respite services and the ethics of surrogate decision making.家庭照护者贯穿该刊文献，涉及照护负担、应对方式、喘息服务以及代理决策的伦理压力。
• Nursing homes and assisted living administrators find material on staffing and quality indicators, along with work on wandering and the reduction of physical restraint.养老院与辅助生活机构的管理者可读到人员配置与质量指标方面的内容，也涉及走失防范和减少身体约束。
• Media reviews of books, films and patient-facing resources appear beside the research papers, a feature carried over from the magazine years.书评、影评与面向患者的资料介绍同研究论文并列，这一栏目延续自改刊前的杂志时期。
• International perspectives are welcomed, and pages regularly carry accounts of European and Asian memory services set against North American practice.期刊欢迎国际视角，经常刊登欧洲与亚洲记忆门诊的实践，并与北美经验对照呈现。
• Public health and policy questions surface as well, including dementia strategy, workforce planning and the cost of care across health and social systems.公共卫生与政策议题同样出现，涉及痴呆症战略、人力规划以及医疗与社会照护体系的费用。
• The stated purpose is practical rather than archival, and authors are asked to draw out what their findings mean for people who deliver care.该刊宗旨偏重实用，要求作者写明研究结果对一线照护者的意义，而不只是存档式的报告。
• Review articles and commentary summarise the state of a question for readers who are not specialists in the underlying science.综述与评论文章面向非本领域专家的读者，梳理某一问题的研究现状。
• Diagnostic disclosure and advance care planning sit within the remit, since both belong to the ordinary work of dementia services.诊断告知与预先照护计划也在范围之内，因为二者都属于痴呆症服务的日常工作。
• Symptom scales and the reporting of neuropsychiatric symptoms are discussed with an eye to how scores translate into care decisions.症状量表与神经精神症状的报告方式得到讨论，重点在于评分如何转化为照护决策。
• Work on younger-onset dementia and on rarer syndromes keeps a place here, since such cases sit awkwardly in the general geriatric literature.早发型痴呆与少见综合征的研究在此保有一席之地，这类病例在通行的老年医学文献中往往不易安放。
• The readership spans physicians and nurses as well as psychiatrists and psychologists, which keeps the prose accessible to a mixed clinical audience.读者群涵盖医生与护士，也面向精神科医师和心理师，行文因此保持跨专业可读。

History

• The journal's lineage starts in 1986, when a magazine for Alzheimer's care practitioners appeared under an earlier title, and the volume numbering has run without a break since then.该刊的谱系可追溯至 1986 年，其前身以旧题名问世，服务对象是阿尔茨海默病照护实务者，卷次编号此后未曾中断。
• The present name was adopted in 2000, when Prime National Publishing of Weston, Massachusetts, repositioned the magazine for a research and clinical readership.现名于 2000 年启用，马萨诸塞州韦斯顿的 Prime National Publishing 把这份杂志重新定位为面向研究与临床读者的刊物。
• MEDLINE followed in January 2001 with volume 16, number 1, and the title has stayed in that database ever since.MEDLINE 于 2001 年 1 月从第 16 卷第 1 期起收录，此后一直保留在该库之中。
• Ownership passed to SAGE Publications, whose current imprint for the title is Thousand Oaks, California, and the National Library of Medicine records the two imprints in sequence.出版权其后转入 SAGE Publications，现行出版地记为加利福尼亚州千橡市，美国国家医学图书馆按先后顺序记录了两段出版信息。
• Frequency settled at eight issues a year from 2010, a rhythm the National Library of Medicine still records, and held until the issue numbers were dropped.自 2010 年起刊期固定为每年 8 期，这一节奏美国国家医学图书馆至今仍有著录，直到期号被取消为止。
• Issue numbers came to an end with volume 34, which ran to issue 7 in 2019. From volume 35 each volume is a continuous run of article-numbered papers.期号止于第 34 卷，该卷在 2019 年出至第 7 期；自第 35 卷起，每卷改为连续编排，论文以文章编号标识。
• Every paper now appears under gold open access, and the JCR entry for 2025 records a gold share of 100 per cent.目前全部论文以金色开放获取形式发表，2025 年 JCR 记录的金色开放获取比例为 100%。
• Impact factors have risen slowly across the decade, from 2.632 in 2022 through 2.7 in both 2023 and 2024 to 3.3 in 2025.影响因子在十年间缓慢上行，2022 年为 2.632，2023 年与 2024 年同为 2.7，2025 年升至 3.3。
• The 2025 figure places the journal at 107 of 296 titles in clinical neurology and 35 of 72 in geriatrics and gerontology.按 2025 年数据，该刊在临床神经病学 296 种期刊中列第 107 位，在老年医学与老年学 72 种期刊中列第 35 位。
• Output is small by the standards of the field, at 22 articles in the 2025 count, against 2887 citations accumulated and a cited half-life of 10.2 years.发文规模在这一领域偏小，2025 年统计为 22 篇，累计被引 2887 次，被引半衰期 10.2 年。
• It is a member of the Committee on Publication Ethics, and its archive is available through PubMed Central.该刊是出版伦理委员会（COPE）的成员，过刊可在 PubMed Central 查阅。
• The 2025 five-year impact factor stands at 3.5 and the Journal Citation Indicator at 0.74, with a field percentile of 64.2025 年五年影响因子为 3.5，期刊引文指标 JCI 为 0.74，学科百分位为 64。

Editors

• The journal keeps its editorial board on a page of its own in the journal menu, beside the submission guidelines and the metrics page, rather than burying it in the submission workflow.该刊的编委会在期刊菜单中单独成页，与投稿指南和计量指标并列，而不是埋在投稿流程里。
• Editorial direction stays close to practice, since the journal is written for researchers, physicians, nurses, psychiatrists and nursing-home administrators who deal with dementia every day.编务取向贴近实践，因为该刊面向的是每日与痴呆症打交道的科研人员、医师、护士、精神科医师与养老机构管理者。
• Day-to-day handling runs through SAGE's editorial office in Thousand Oaks, which receives submissions and manages correspondence with authors.日常编务由 SAGE 设在千橡市的编辑办公室承担，负责接收投稿并与作者通信。
• All research papers are externally reviewed before acceptance, and the journal applies the Committee on Publication Ethics framework to disputes over authorship and data.所有研究论文在录用前均经外部评审，期刊在作者署名与数据争议上适用出版伦理委员会的规范。
• Assessment leans on usefulness, and reviewers are asked whether a paper changes what a clinician, nurse or care-home manager would do next week.评审侧重实用性，审稿人需要判断论文是否会改变临床医生、护士或养老院管理者下周的做法。
• That bias towards practice explains why short case studies and book or film reviews sit beside trial reports without any sense of demotion.这种偏重实践的取向解释了为何短篇病例与书评影评能和试验报告并列，而不显得次要。
• Authors must spell out the implications for care in plain language that a mixed readership can follow.作者需要以平实语言说明研究结果对照护的意义，让跨专业读者都能读懂。
• Submissions from outside North America are welcomed, and the scope statement sets no geographic restriction on authorship.期刊欢迎北美以外的投稿，其征稿说明未对作者所在地区设限。
• The publisher describes those readers as the people on the front line of dementia care, and that description sets the test a paper has to pass.出版方把读者描述为站在痴呆症照护一线的人，这一描述也就成了论文必须通过的检验。